/
MDIT
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.01
2% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | |
|---|---|---|---|
| Revenue | $9.9M | $9.2M | $6.8M |
| Cost of revenue | $6.3M | $5.8M | $6.9M |
| Gross profit | $3.6M | $3.4M | −$131.0K |
| Gross margin | 36.7% | 37.0% | -1.9% |
| R&D | $1.3M | $1.5M | $1.2M |
| Operating income | −$599.0K | −$1.7M | −$6.5M |
| EBITDA | −$422.0K | −$1.4M | −$6.2M |
| Net income | −$859.0K | −$2.2M | −$6.8M |
| Net margin | -8.7% | -23.4% | -100.0% |
| EPS (diluted) | -0.04 | -0.10 | -0.26 |
Annual figures · source: Financial Modeling Prep
Peer comparison
MEDITE CANCER DIAGNOSTICS
MEDITE CANCER DIAGNOSTICS
Held by traders on TradeandTell
No one on the platform currently holds MDIT.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in MDIT as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2015-03-12 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded MDIT yet.